Method for preparing soluble HIV-1 integrase recombinant protein
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- BEIJING UNIV OF TECH
- Publication Date
- 2015-03-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology, and in particular relates to a preparation method of soluble HIV-1 integrase recombinant protein. Background technique
[0002] HIV-1 integrase is encoded by the HIV-1 pol gene, contains 288 amino acid residues, and has a molecular weight of about 32 kDa. Integrase catalyzes the integration of HIV-1 cDNA formed by reverse transcription into the genome of host cells, which is an essential link in the HIV-1 replication cycle. Since there are no functional analogues of integrase in human cells, inhibitors acting on integrase have little potential side effects on the human body, so integrase is considered to be an ideal target for anti-HIV-1 drug research.
[0003] In the mechanism and drug research related to HIV-1 integrase, it is usually necessary to prepare recombinant integrase protein by means of prokaryotic expression and purification. However, when using existing prokaryotic expression and puri...